Howe Jolanda: insider trades.
Howe Jolanda reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($4.6M), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Howe Jolanda
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | Officer · SVP, GLOBAL CONTROLLER | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Mirum Pharmaceuticals, Inc. | S | 658 | $100 | 616 | Form 4 |
| 2026-08-18 | Mirum Pharmaceuticals, Inc. | S | 40,000 | $100 | 1,274 | Form 4 |
| 2026-08-18 | Mirum Pharmaceuticals, Inc. | M | 40,000 | $6.27 | 41,274 | Form 4 |
| 2026-08-03 | Mirum Pharmaceuticals, Inc. | S | 1,840 | $105.29 | 1,274 | Form 4 |
| 2026-07-01 | Mirum Pharmaceuticals, Inc. | S | 2,721 | $120 | 3,114 | Form 4 |
Questions
What stock did Howe Jolanda buy or sell?
Howe Jolanda reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($4.6M), across 1 company.
Is Howe Jolanda the same person as other filers with this name?
This page covers SEC CIK 1974200 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/howe-jolanda-1974200.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.